Bone marrow transplantation: Does it stop MS progression?

Journal of the Neurological Sciences

Volumn 259, Issue 1-2, 2007, Pages 85-89

  Freedman, Mark S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bone marrow transplantation; Immunosuppression; Multiple sclerosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; IMMUNOGLOBULIN; MELPHALAN; THYMOCYTE ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CAPILLARY LEAK SYNDROME; DISEASE COURSE; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MULTIPLE SCLEROSIS; PATIENT SELECTION; PRIORITY JOURNAL; REMISSION; VEIN OCCLUSION;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS;

EID: 34447109557     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.10.023     Document Type: Article

References (28)

1. Lucchinetti C.F., Parisi J., and Bruck W. The pathology of multiple sclerosis. Neurol Clin 23 1 (2005) 77-105 vi
2. Morales Y., Parisi J.E., and Lucchinetti C.F. The pathology of multiple sclerosis: evidence for heterogeneity. Adv Neurol 98 (2006) 27-45
3. Atkins H., and Freedman M. Immunoablative therapy as a treatment aggressive multiple sclerosis. Neurol Clin 23 1 (2005) 273-300 ix
4. Karussis D., Vourka-Karussis U., Mizrachi-Koll R., and Abramsky O. Acute/relapsing experimental autoimmune encephalomyelitis: induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation. Mult Scler 5 1 (1999) 17-21
5. van Gelder M., and van Bekkum D.W. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant 18 6 (1996) 1029-1034
6. van Gelder M., Kinwel-Bohre E.P., and van Bekkum D.W. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 11 3 (1993) 233-241
7. Brazelton T.R., Rossi F.M., Keshet G.I., and Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 5497 (2000) 1775-1779
8. Mezey E., Key S., Vogelsang G., Szalayova I., Lange G.D., and Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A 100 3 (2003) 1364-1369
9. Eglitis M.A., and Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A 94 8 (1997) 4080-4085
10. Crain B.J., Tran S.D., and Mezey E. Transplanted human bone marrow cells generate new brain cells. J Neurol Sci 233 1-2 (2005) 121-123
11. Mezey E. Commentary: on bone marrow stem cells and openmindedness. Stem Cells Dev 13 1 (2004) 147-152
12. Foote A.K., and Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128 Pt 3 (2005) 528-539
13. Samijn J.P.A., Boekhorst P.A.W.t., Mondria T., van Doorn P.A., Flach H.Z., van der Meché F.G.A., Cornelissen J., Hop W.C., Löwenberg B., and Hintzen R.Q. Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry 77 1 (2006) 46-50
14. Havrdova E. Aggressive multiple sclerosis-is there a role for stem cell transplantation?. J Neurol 252 Suppl 3 (2005) iii34-iii37
15. Hintzen R.Q. Stem cell transplantation in multiple sclerosis: multiple choices and multiple challenges. Mult Scler 8 2 (2002) 155-160
16. van Bekkum D.W. Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases. J Leukoc Biol 72 4 (2002) 609-620
17. Tyndall A., and Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 141 1 (2005) 1-9
18. Nash R.A., Bowen J.D., McSweeney P.A., Pavletic S.Z., Maravilla K.R., and Park M.-s. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 102 7 (2003) 2364-2372
19. Burt R.K., Cohen B.A., Russell E., Spero K., Joshi A., Oyama Y., et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 102 7 (2003) 2373-2378
20. Carreras E., Saiz A., and Marin P. CD34+selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 88 3 (2003) 306-314
21. Saiz A., Blanco Y., Carreras E., Berenguer J., Rovira M., Pujol T., et al. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology 62 2 (2004) 282-284
22. Rossiev V.A., Makarov S.V., and Aleksandrova I. Experience with high-dose immunosuppressive therapy followed by transplantation of autologous stem hematopoietic cells in patients with multiple sclerosis. Ter Arkh 74 7 (2002) 35-38
23. Kozák T., Havrdová E., Pit'ha J., Gregora E., Pytlík R., Maaloufová J., et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 25 5 (2000) 525-531
24. Kozak T., Havrdova E., and Pit'ha J. Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis. Transplant Proc 33 3 (2001) 2179-2181
25. Openshaw H., Lund B.T., Kashyap A., Atkinson R., Sniecinski I., Weiner L.P., et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 6 5A (2000) 563-575
26. Fassas A., Anagnostopoulos A., Kazis A., Kapinas K., Sakellari I., Kimiskidis V., et al. Autologous stem cell transplantation in progressive multiple sclerosis-an interim analysis of efficacy. J Clin Immunol 20 1 (2000) 24-30
27. Mancardi G.L., Saccardi R., Filippi M., Gualandi F., Murialdo A., Inglese M., et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57 1 (2001) 62-68
28. Sun W., Popat U., Hutton G., Zang Y.C.Q., Krance R., Carrum G., et al. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 127 Pt 5 (2004) 996-1008